FDA clears Teva's generic version of acne drug Solodyn

03/18/2009 | Globes (Israel) · Reuters

Teva Pharmaceutical Industries obtained FDA approval to market 45-mg, 90-mg and 135-mg doses of its copy of Solodyn, an acne medicine from Medicis Pharmaceutical. The decision was announced the same day that the companies ended their patent dispute over the launch of generic Solodyn.

View Full Article in:

Globes (Israel) · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA